Jennifer is a biomolecular engineer who, during her PhD at Dartmouth College worked on designing next-generation vaccines to drive immune responses to target specific virus vulnerabilities. In the contexts of HIV-1 and Dengue virus, this approach aims to selectively elicit protective antibodies and avoid raising antibodies that may run the risk of enhancing disease.
As a Schmidt Science Fellow, Jennifer pivoted into computational immunology working with Dr. Michael Mina at the Center for Communicable Disease Dynamics to use high-throughput tools and analytical methods to investigate how the antibody response develops over time during pregnancy and influences early immunity in young infants.
She is now a Scientific Manager at The Broad Institute of MIT and Harvard.
Jennifer is motivated by a long-standing fascination with the body’s immune defenses and hopes to provide high-resolution understanding of humoral immunity towards informing best vaccination practices and improved therapeutic strategies.